BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21073190)

  • 1. Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonists.
    Yang BV; Weinstein DS; Doweyko LM; Gong H; Vaccaro W; Huynh T; Xiao HY; Doweyko AM; McKay L; Holloway DA; Somerville JE; Habte S; Cunningham M; McMahon M; Townsend R; Shuster D; Dodd JH; Nadler SG; Barrish JC
    J Med Chem; 2010 Dec; 53(23):8241-51. PubMed ID: 21073190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocyclic glucocorticoid receptor modulators with a 2,2-dimethyl-3-phenyl-N-(thiazol or thiadiazol-2-yl)propanamide core.
    Xiao HY; Wu DR; Sheppeck JE; Habte SF; Cunningham MD; Somerville JE; Barrish JC; Nadler SG; Dhar TG
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5571-4. PubMed ID: 24011644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
    Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists.
    Sheppeck JE; Gilmore JL; Xiao HY; Dhar TG; Nirschl D; Doweyko AM; Sack JS; Corbett MJ; Malley MF; Gougoutas JZ; Mckay L; Cunningham MD; Habte SF; Dodd JH; Nadler SG; Somerville JE; Barrish JC
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5442-7. PubMed ID: 23953070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826).
    Weinstein DS; Gong H; Doweyko AM; Cunningham M; Habte S; Wang JH; Holloway DA; Burke C; Gao L; Guarino V; Carman J; Somerville JE; Shuster D; Salter-Cid L; Dodd JH; Nadler SG; Barrish JC
    J Med Chem; 2011 Oct; 54(20):7318-33. PubMed ID: 21899328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of novel indazolyl glucocorticoid receptor partial agonists.
    Gilmore JL; Sheppeck JE; Wang J; Dhar TG; Cavallaro C; Doweyko AM; Mckay L; Cunningham MD; Habte SF; Nadler SG; Dodd JH; Somerville JE; Barrish JC
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5448-51. PubMed ID: 23916594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel dihydro-9,10-ethano-anthracene carboxamides as glucocorticoid receptor modulators.
    Yang BV; Vaccaro W; Doweyko AM; Doweyko LM; Huynh T; Tortolani D; Nadler SG; McKay L; Somerville J; Holloway DA; Habte S; Weinstein DS; Barrish JC
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2139-43. PubMed ID: 19321341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of highly efficacious glucocorticoid receptor agonists with a potential for reduced clinical bone side effects.
    Harcken C; Riether D; Kuzmich D; Liu P; Betageri R; Ralph M; Emmanuel M; Reeves JT; Berry A; Souza D; Nelson RM; Kukulka A; Fadra TN; Zuvela-Jelaska L; Dinallo R; Bentzien J; Nabozny GH; Thomson DS
    J Med Chem; 2014 Feb; 57(4):1583-98. PubMed ID: 24506830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases.
    Kato M; Hagiwara Y; Oda T; Imamura-Takai M; Aono H; Nakamura M
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):353-60. PubMed ID: 21574866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore.
    Razavi H; Riether D; Harcken C; Bentzien J; Dinallo RM; Souza D; Nelson RM; Kukulka A; Fadra-Khan TN; Pack EJ; Zuvela-Jelaska L; Pelletier J; Panzenbeck M; Torcellini CA; Proudfoot JR; Nabozny GH; Thomson DS
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1934-40. PubMed ID: 24656565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.
    Barker M; Clackers M; Copley R; Demaine DA; Humphreys D; Inglis GG; Johnston MJ; Jones HT; Haase MV; House D; Loiseau R; Nisbet L; Pacquet F; Skone PA; Shanahan SE; Tape D; Vinader VM; Washington M; Uings I; Upton R; McLay IM; Macdonald SJ
    J Med Chem; 2006 Jul; 49(14):4216-31. PubMed ID: 16821781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure guided design of 5-arylindazole glucocorticoid receptor agonists and antagonists.
    Yates CM; Brown PJ; Stewart EL; Patten C; Austin RJ; Holt JA; Maglich JM; Angell DC; Sasse RZ; Taylor SJ; Uings IJ; Trump RP
    J Med Chem; 2010 Jun; 53(11):4531-44. PubMed ID: 20469868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity.
    Biggadike K; Boudjelal M; Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Needham D; Skone PA; Uings I; Veitch G; Weingarten GG; McLay IM; Macdonald SJ
    J Med Chem; 2007 Dec; 50(26):6519-34. PubMed ID: 18038970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octahydrophenanthrene-2,7-diol analogues as dissociated glucocorticoid receptor agonists: discovery and lead exploration.
    Robinson RP; Buckbinder L; Haugeto AI; McNiff PA; Millham ML; Reese MR; Schaefer JF; Abramov YA; Bordner J; Chantigny YA; Kleinman EF; Laird ER; Morgan BP; Murray JC; Salter ED; Wessel MD; Yocum SA
    J Med Chem; 2009 Mar; 52(6):1731-43. PubMed ID: 19239259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal dissociated glucocorticoid agonists containing azaindoles as steroid A-ring mimetics.
    Riether D; Harcken C; Razavi H; Kuzmich D; Gilmore T; Bentzien J; Pack EJ; Souza D; Nelson RM; Kukulka A; Fadra TN; Zuvela-Jelaska L; Pelletier J; Dinallo R; Panzenbeck M; Torcellini C; Nabozny GH; Thomson DS
    J Med Chem; 2010 Sep; 53(18):6681-98. PubMed ID: 20735001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of betamethasone 17alpha-carbamates as dissociated glucocorticoid receptor modulators in the rat.
    Ali A; Balkovec JM; Greenlee M; Hammond ML; Rouen G; Taylor G; Einstein M; Ge L; Harris G; Kelly TM; Mazur P; Pandit S; Santoro J; Sitlani A; Wang C; Williamson J; Forrest MJ; Carballo-Jane E; Luell S; Lowitz K; Visco D
    Bioorg Med Chem; 2008 Aug; 16(16):7535-42. PubMed ID: 18691892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal 2,3-dihydroquinoline glucocorticoid receptor agonists with reduced PEPCK activation.
    Hudson AR; Higuchi RI; Roach SL; Valdez LJ; Adams ME; Vassar A; Rungta D; Syka PM; Mais DE; Marschke KB; Zhi L
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1654-7. PubMed ID: 21324689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal dissociated glucocorticoid agonists: indoles as A-ring mimetics and function-regulating pharmacophores.
    Betageri R; Gilmore T; Kuzmich D; Kirrane TM; Bentzien J; Wiedenmayer D; Bekkali Y; Regan J; Berry A; Latli B; Kukulka AJ; Fadra TN; Nelson RM; Goldrick S; Zuvela-Jelaska L; Souza D; Pelletier J; Dinallo R; Panzenbeck M; Torcellini C; Lee H; Pack E; Harcken C; Nabozny G; Thomson DS
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6842-51. PubMed ID: 21963986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid amides as novel glucocorticoid receptor modulators.
    Sharma R; Prichard D; Majer F; Byrne AM; Kelleher D; Long A; Gilmer JF
    J Med Chem; 2011 Jan; 54(1):122-30. PubMed ID: 21158453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines.
    Kym PR; Kort ME; Coghlan MJ; Moore JL; Tang R; Ratajczyk JD; Larson DP; Elmore SW; Pratt JK; Stashko MA; Falls HD; Lin CW; Nakane M; Miller L; Tyree CM; Miner JN; Jacobson PB; Wilcox DM; Nguyen P; Lane BC
    J Med Chem; 2003 Mar; 46(6):1016-30. PubMed ID: 12620078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.